Faculty Opinions recommendation of A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome.
2009 ◽
Vol 37
(6)
◽
pp. 1874-1880
◽
2010 ◽
Vol 2010
◽
pp. 190-191
2008 ◽
Vol 36
(3)
◽
pp. 782-788
◽